Sawai Pharmaceutical Co. Ltd. | |
Stock Exchange | Other OTC |
EPS |
$3.98 |
Market Cap |
$2.47 B |
Shares Outstanding |
44.08 M |
Public Float |
- |
Sawai Pharmaceutical Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY442.32 |
Market Cap |
JPY267.48 B |
Shares Outstanding |
44.08 M |
Public Float |
36.82 M |
Address |
5-2-30 Miyahara Osaka Osaka 532 Japan |
Employees | - |
Website | http://www.sawai.co.jp |
Updated | 07/08/2019 |
Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. |